Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme.
Journal article published in 2018 by
Rebecca Fish 
,
Andrew G. Renehan,
Grant Punnett,
Omer Aziz,
Paul E. Fulford,
Chelliah Selvasekar,
Malcolm S. Wilson,
Rebecca Halstead,
Sarah T. O'Dwyer
,
Andrew G. Renehan,
Grant Punnett,
Omer Aziz,
Paul E. Fulford,
Chelliah Selvasekar,
Malcolm S. Wilson,
Rebecca Halstead,
Sarah T. O'Dwyer
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Pseudomyxoma peritonei (PMP) is a rare neoplasm of the appendix, which if untreated disseminates throughout the abdominal cavity and generates considerable morbidity. Since 2002 in the UK, patients with PMP have been managed via two nationally commissioned centres. We evaluated referrals and treatment pathways over time at the Manchester centre.